Innovative method could offer cost-effective sterilisation approach
19 March 2024
The new sterilisation method could provide an affordable, rapid approach for preparing microbiological culture media, research suggests.
In 2023, Russia has registered 540 drugs
19 March 2024
In 2023, the Russian Ministry of Health registered a total of 540 medicines, with less than half, specifically 160 (29.6%), being of foreign origin. This was stated by the head of the department, Mikhail Murashko, emphasizing that “Russian pharma has begun to create innovative products.”
Rapid pseudomonas aeruginosa detection method developed
18 March 2024
Research suggests the rapid detection method “will enable the timely implementation of microbiological monitoring strategies for large batches of medications”.
Health Ministry has approved a drug for the treatment of Niemann–Pick disease
18 March 2024
The Ministry of Health of the Russian Federation issued a regulatory certificate to the Dutch company Genzyme Europe (Genzyme has been owned by Sanofi since 2011) for the drug Zenpozyme (olipudase alfa), intended for the treatment of a rare genetic disease – Niemann-Pick disease A/B and B types. In 2023, this disease was included in the roster of conditions entitling individuals to receive treatment funded by the “Circle of Kindness” state fund.
Positive study results in 298 patients with obstructive sleep apnea (OSA)
15 March 2024
Desitin, an expert in neurological and psychiatric therapeutics, reports positive study results from the FLOW study with 298 patients: Nocturnal breathing pauses in patients with obstructive sleep apnea (OSA) were significantly reduced, thus meeting the primary endpoint of the study. With these positive results, a reliable basis for the final clinical phase 3 development of the first oral treatment for OSA has been established. While OSA has serious health implications, only around a third of all patients use the gold standard therapy of Continuous Positive Airway Pressure (CPAP) long-term.
Rapid pseudomonas aeruginosa detection method developed
15 March 2024
Research suggests the rapid detection method “will enable the timely implementation of microbiological monitoring strategies for large batches of medications”. Findings from an experimental study report the development of a rapid method for the detection of pseudomonas aeruginosa bacteria in medications.
Developing new treatment regimens for HIV
14 March 2024
Since the HIV epidemic began in the early 1980s, more than 85 million people have been diagnosed worldwide and about 40 million have died as a result of complications from the virus.1 Now, four decades later, 39 million people around the world are living with HIV, primarily due to advances in treatment.1 With continued innovation on the horizon in terms of prevention and treatment methods, what was once a wishful hope of ending the epidemic has become a conceivable goal.
Life sci marketing budgets boomed in 2023, led by spending on trade shows and websites, survey finds
14 March 2024
Marketing cut a bigger slice of the budgetary pie at life sciences companies in 2023, a recent survey has found. After several COVID-inflected years that saw companies allotting smaller percentages of their total revenues to marketing, 2023 ushered in a return nearly to pre-pandemic levels.
Metabolic disorders lab opens in Siberia
13 March 2024
A laboratory of experimental biochemistry and biology has been established at the Siberian State Medical University, where dedicated scientists will be pioneering the search for new markers to facilitate early disease detection, with a special focus on researching metabolic disorders. Here, they are planning to conduct research, develop and implement laboratory workshops and final qualification projects, as well as hold career guidance sessions for schoolchildren.
70% of drugs put into circulation in 2023 are Russian-made
12 March 2024
Previously, Russian media said that there is a medicine shortage in Russia. However, the Russian Ministry of Health denied the information. On the contrary, according to the Ministry, the situation on the domestic pharmaceutical market is stable.
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Grand finale from a veritable stalwart of neuroscience
09 November 2023
Battle of pharma advocates – in search of the ideal migraine therapy
09 November 2023